Ventyx Biosciences, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Ventyx was bought by Eli Lilly; shareholders received cash for their shares instead of owning stock.
Stockholders approved the deal announced January 7, 2026 making Ventyx a wholly owned Eli Lilly subsidiary.
Extra information was shared to help shareholders understand all details about the Eli Lilly acquisition.
Company leadership including CEO Raju Mohan received bonus payments for performance goals.
Stocky reads Ventyx Biosciences, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Ventyx Biosciences, Inc.'s most recent tracked filing was a 8-K on 4 Mar 2026: Eli Lilly merger completed, stock converted to cash payouts.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.